Arca Biopharma | ABIO - DEBITO





DEBITO Cambiamento Data
Alterity Therapeutics Limited AUD 210.39K 120.67K 2023-06
Amgen USD 54.6B 17M 2025-12
Arca Biopharma USD 0 0 2025-03
Biogen USD 6.56B 275.1M 2026-03
Brainstorm Cell Therapeutics USD 1.2M 1.2M 2025-03
Bristol-Myers Squibb USD 47.14B 3.9B 2025-12
Capricor Therapeutics USD 3.38M 0 2025-03
Cipla INR 4.38B 231.9M 2025-03
Clal Biotechnology ILS 35.76M 28.27M 2023-12
Compugen USD 2.95M 24K 2025-09
CSL USD 11.96B 219M 2024-12
Cytokinetics USD 1.29B 4.48M 2026-03
Daiichi Sankyo JPY 201.14B 99.81B 2025-09
Gilead Sciences USD 24.94B 5M 2025-12
GlaxoSmithKline GBP 19.06B 1.34B 2026-03
Grifols EUR 9.23B 626.05M 2024-12
Laboratory Of America USD 6.53B 3.9M 2025-12
Myriad Genetics USD 59.3M 19.7M 2025-03
Otsuka Holdings JPY 227.98B 16.47B 2025-12
Pfizer USD 63.73B 231M 2026-03
United Therapeutics USD 200M 100M 2025-03